KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $5,000 | -37.5% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |